Robert Baffi, EVP, Technical Operations at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 20,000 shares at $67.00 ($1.3M) on 2013-05-03, disclosed to the SEC on 2013-05-07.
Scheduled sale ($1.3M) by EVP, Technical Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BMRN | SELL | 2017-10-02 | $2.0M | — | Filing → |
| BMRN | SELL | 2016-05-19 | $435K | — | Filing → |
| BMRN | SELL | 2015-03-05 | $1.6M | — | Filing → |